Cargando…
Inhibition of CYP2C8 by Acyl Glucuronides of Gemfibrozil and Clopidogrel: Pharmacological Significance, Progress and Challenges
The lipid-regulating drug gemfibrozil is a useful medication for reducing high cholesterol and triglycerides in the blood. In addition to oxidation, it undergoes extensive glucuronidation to produce gemfibrozil acyl glucuronide, which is a known mechanism-based inactivator of cytochrome P450 (CYP) 2...
Autor principal: | Shah, Manish B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496539/ https://www.ncbi.nlm.nih.gov/pubmed/36139056 http://dx.doi.org/10.3390/biom12091218 |
Ejemplares similares
-
2D QSAR Study for Gemfibrozil Glucuronide as the Mechanism-based Inhibitor of CYP2C8
por: Taxak, N., et al.
Publicado: (2013) -
Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8‐Mediated Metabolism of Montelukast in Humans
por: Itkonen, Matti K., et al.
Publicado: (2017) -
Pharmacological preconditioning with gemfibrozil preserves cardiac function after heart transplantation
por: Benke, Kálmán, et al.
Publicado: (2017) -
Acylated Flavone O-Glucuronides from the Aerial Parts of Nepeta curviflora
por: Rabee, Maysaa, et al.
Publicado: (2020) -
Bullous dermatosis of childhood induced by gemfibrozil
por: Abtahi-Naeini, Bahareh, et al.
Publicado: (2015)